Article
Chromosomal microarray analysis in a cohort of underrepresented population identifies SERINC2 as a novel candidate gene for autism spectrum disorder.
Scientific reports - 21 Sept 2017
Hnoonual Areerat, Thammachote Weerin, Tim-Aroon Thipwimol, Rojnueangnit Kitiwan, Hansakunachai Tippawan, Sombuntham Tasanawat, Roongpraiwan Rawiwan, Worachotekamjorn Juthamas, Chuthapisith Jariya, Fucharoen Suthat, Wattanasirichaigoon Duangrurdee, Ruangdaraganon Nichara, Limprasert Pornprot, Jinawath Natini
Abstract excerpt
Chromosomal microarray (CMA) is now recognized as the first-tier genetic test for detection of copy number variations (CNVs) in patients with autism spectrum disorder (ASD). The aims of this study were to identify known and novel ASD associated-CNVs and to evaluate the diagnostic yield of CMA in Thai patients with ASD. The Infinium CytoSNP-850K BeadChip was used to detect CNVs in 114 Thai patients comprised of 68...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
